Zobrazeno 1 - 10
of 55
pro vyhledávání: '"John Seal"'
Autor:
Kelley G Núñez, Anderson Frank, Janet Gonzalez-Rosario, Gretchen Galliano, Kim Bridle, Darrell Crawford, John Seal, Frank Abbruscato, Himanshu Vashistha, Paul T Thevenot, Ari J Cohen
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0216242 (2019)
Transplanting donor livers with severe macrosteatosis is associated with increased risk of primary non-function (PNF). The purpose of this study was to identify steatosis-driven biomarkers as a predisposition to severe liver damage and delayed recove
Externí odkaz:
https://doaj.org/article/f8af69e5398d43a6b9e2f450cc99ebed
Three-Dimensional Visualization With Virtual Reality Facilitates Complex Live Donor Renal Transplant
Autor:
Dennis Sonnier, W. Peter Sawyer, John Seal, Colin Curtis, Jack McGee, Alec Slayden, Korak Sarkar
Publikováno v:
Ochsner Journal. 22:344-348
Publikováno v:
The Ochsner Journal
Background: Directed blood donation is defined as the donation of blood or its components for the purpose of transfusion into a specified individual. Directed blood donation holds historic significance, and although practices as of 2021 encourage vol
Autor:
Marisa L Doran, Dennis I Sonnier, David S Bruce, Humberto E Bohorquez, Ian C Carmody, Adam S A Gracon, John Seal, Ari J Cohen
Publikováno v:
Journal of the American College of Surgeons. 235:S84-S84
Autor:
John Seal, Ari J. Cohen, S. Anders, Jonathan Hand, Ian Carmody, Dennis Sonnier, Nigel Girgrah, George Therapondos, George E. Loss, David Bruce, Jennifer Scheuermann, Shobha Joshi, Natalie Bzowej, Humberto Bohorquez, Emily Bugeaud
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyReferences. 27(4)
Liver transplantation (LT) using allografts from hepatitis C virus (HCV)-viremic/nucleic acid testing-positive donors' (DNAT+) organs into HCV-aviremic recipients (rHCV-) has been limited owing to nearly universal HCV transmission and concerns regard
Autor:
Hernan A. Bazan, Clayton J. Brinster, W. Charles Sternbergh, Taylor A. Smith, Leighton E. Goldsmith, Kristy Wiebke, John Seal
Publikováno v:
Journal of Vascular Surgery. 66:1488-1496
Hepatic artery stenosis (HAS) after liver transplantation can progress to hepatic artery thrombosis (HAT) and a subsequent 30% to 50% risk of graft loss. Although endovascular treatment of severe HAS after liver transplantation has emerged as the dom
Autor:
Nigel Girgrah, Narendra Battula, Gene W. Tyson, Humberto Bohorquez, David Bruce, Emily Bugeaud, Trevor Reichman, John Seal, George E. Loss, N. Bzowej, G. Therapondos, Ian Carmody, Shobha Joshi, M. Alsaggaf, Ramona Nicolau-Raducu, Adam Kressel, Ari J. Cohen
Publikováno v:
American Journal of Transplantation. 17:2155-2164
Donation after circulatory death (DCD) liver transplantation (LT) reportedly yields inferior survival and increased complication rates compared with donation after brain death (DBD). We compare 100 consecutive DCD LT using a protocol that includes th
Autor:
Emily Bugeaud, George E. Loss, Trevor Reichman, Gretchen Galliano, Humberto Bohorquez, John Seal, Yamah Amiri, Ian Carmody, Ari J. Cohen, David Bruce, Narendra Battula
Publikováno v:
Liver Transplantation. 23:299-304
Background: Liver transplantation (LT) offers the best chance of survival in selected patients with hepatocellular carcinoma (HCC). Wait list mortality or dropout due to tumor progression can be significant and therefore timely transplantation is cri
Autor:
George Therapondas, Ian Carmody, Trevor Reichman, Shoba Joshi, Ari J. Cohen, George E. Loss, Emily Ahmed, Humberto Bohorquez, John Seal, Natalie Bzowej, David Bruce, Narendra Battula, Nigel Girgrah
Publikováno v:
American Journal of Transplantation. 16:9-90
Autor:
Martha Alicia De La Rosa, Kurt Weaver, Lisa M. Shewchuk, Rachel D. Totoritis, John Seal, David Favre, Guofeng Zhang, Makda Mebrahtu, Tia Lewis, Marcel Muelbaier, Richard M. Dunham, Giovanna Bergamini, Jeffrey Guss, Alan R. Rendina, Nino Campobasso, Wieslaw M. Kazmierski, Douglas W. Thomson, Robert Midgett, Katrin Strohmer, Anna Rutkowska-Klute, Rosalie Matico, Thomas Consler, Cunyu Zhang, David Taylor, Sabrina Bédard, Rodrigo F Ortiz-Meoz, Liping Wang
Indoleamine-2,3-dioxygenase 1 (IDO1) is a heme-containing enzyme that catalyzes the rate-limiting step in the kynurenine pathway of tryptophan (TRP) metabolism. As an inflammation-induced immunoregulatory enzyme, pharmacological inhibition of IDO1 ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d6eedaf9b8c5819ab8c1e04bab343a2
https://doi.org/10.1101/324947
https://doi.org/10.1101/324947